BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

  Management will host a webcast and conference call that day at 8:30 a.m. ET to discuss these results and updates.

  October 30, 2017

   · 

  1 min read
• MiMedx CEO Replies to Fraudulent Information About the Company

  MiMedx announced today that the Company’s Chairman and CEO, Parker H. “Pete” Petit, has replied directly to shortseller Marc Cohodes’ letter to Mr. Petit dated October 27, 2017.

  October 30, 2017

   · 

  2 min read
• Business

  Portola Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 6

  The company will host a webcast and conference call to discuss the company’s financial results the same day.

  October 30, 2017

   · 

  1 min read
• Drug Development

  Five Prime Therapeutics Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity With FPT155

  October 30, 2017

   · 

  4 min read
• Biotech Bay

  Episona Presents Data on Sperm DNA Methylation Patterns at ASRM Congress Expo

  Episona announced data of a prospective, controlled, multi-institutional clinical trial of 210 patients which appears to illustrate emerging and robust relationships between sperm DMPs and abnormal semen parameters among infertile couples.

  October 30, 2017

   · 

  2 min read
• Pharm Country

  Ferring Pharma Presents New Data Comparing MENOPUR (Menotropins for Injection) to rFSH in High Responder Patients

  Ferring Pharma’s MEGASET HR study met its primary non-inferiority endpoint, with MENOPUR-treated patients reporting a 29.7% ongoing pregnancy rate per cycle start in the fresh cycle compared to 25.6% for rFSH.

  October 30, 2017

   · 

  5 min read
• Business

  Daiichi Sankyo Working with Berkeley Lights’ Beacon OptoFluidic Platform for Cell Line Development

  Berkeley Lights announced today a program with Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.

  October 30, 2017

   · 

  2 min read
• Pharm Country

  Takeda and the New York Academy of Sciences Announce Innovators in Science Award Honorees

  The Winner of the Senior Scientist Award is Shigetada Nakanishi, M.D., Ph.D., Director, Suntory Foundation for Life Sciences Bioorganic Research Institute in Japan.

  October 30, 2017

   · 

  6 min read
• Drug Development

  Syros Presents New Preclinical PK and PD Data for SY-1365, Its First-in-Class Selective CDK7 Inhibitor, at AACR-NCI-EORTC Conference

  Syros Pharmaceuticals announced that new preclinical pharmacodynamic and pharmacokinetic data providing a rationale for the twice weekly dosing regimen currently being used in the ongoing Phase 1 clinical trial of SY-1365.

  October 30, 2017

   · 

  7 min read
• FDA

  Novaliq’s NovaTears Treatment for Evaporative Dry Eye Disease Launches in New Zealand and Receives Registrational Approval in Australia

  NovaTears immediately stabilizes the lipid layer without causing vision blurring.

  October 30, 2017

   · 

  4 min read